Nothing Special   »   [go: up one dir, main page]

EP2747704A1 - Double stent en plastique auto-expansible - Google Patents

Double stent en plastique auto-expansible

Info

Publication number
EP2747704A1
EP2747704A1 EP11785280.6A EP11785280A EP2747704A1 EP 2747704 A1 EP2747704 A1 EP 2747704A1 EP 11785280 A EP11785280 A EP 11785280A EP 2747704 A1 EP2747704 A1 EP 2747704A1
Authority
EP
European Patent Office
Prior art keywords
stent
fibre
radiopaque
proximal end
degradable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP11785280.6A
Other languages
German (de)
English (en)
Inventor
Karel Volenec
Petr Kubena
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ella-CS sro
Ella CS sro
Original Assignee
Ella-CS sro
Ella CS sro
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ella-CS sro, Ella CS sro filed Critical Ella-CS sro
Publication of EP2747704A1 publication Critical patent/EP2747704A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/848—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents having means for fixation to the vessel wall, e.g. barbs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2002/044—Oesophagi or esophagi or gullets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/848—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents having means for fixation to the vessel wall, e.g. barbs
    • A61F2002/8483—Barbs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2220/0025—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
    • A61F2220/005—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements using adhesives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0014—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
    • A61F2250/0032—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in radiographic density
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
    • A61F2250/0096—Markers and sensors for detecting a position or changes of a position of an implant, e.g. RF sensors, ultrasound markers
    • A61F2250/0098—Markers and sensors for detecting a position or changes of a position of an implant, e.g. RF sensors, ultrasound markers radio-opaque, e.g. radio-opaque markers

Definitions

  • the invention relates to a self-expanding dual plastic stent prepared from radiopaque fibres and coated with an elastic foil as well as to the method of manufacturing the same.
  • the present invention pertains to the field of medical technology, particularly to the field of elastic reinforcements, such as stents.
  • Stents and stent grafts are tubular formations made from a meshwork using the braiding technique or made from a tubule using the laser trimming technique.
  • the main function of the stents is to ensure the patency of tubular organs inside the human body when the essential patency is restricted in an acute or chronic manner.
  • restriction or constriction
  • Such restriction may be caused, e.g., by a proliferating tumor, which oppresses the affected tubular organ; or may develop after a major surgery.
  • stents are manufactured from a plurality of metallic materials ranging from stainless steels up to the materials having a shape memory, such as those on the basis of nickel-titanium alloys.
  • the first approach is based on the employment of a knitting technique used to form a tubular piece from at least one wire.
  • Such stents may be different in shape, ranging from simple cylindrical tubes, such as those disclosed in the documents U.S. 2010/0249901 and U.S. 2008/111716, up to complex tubular formations which are flared at their individual ends with the aim to eliminate the undesirable migration of the stent, such as those disclosed in the documents U S. 2011/0022 51 and WO 2009/091899.
  • the second method of manufacturing stents is based on the employment of a laser trimming technique.
  • the stents When prepared in the above described manner, the stents always have an original design. Such stents are mostly balloon-expandable and have to be post-dilated in order to assume their nominal diameter. This means that the use of a balloon catheter is inevitable. After having been inserted into the stent, the balloon is inflated. This causes the stent to be expanded and to assume its final diameter.
  • One of the advantages of the above stents, in comparison to classic braided ones, consists in their high rigidity, i.e. high expansion strength. An exemplary embodiment of such stent is disclosed in U.S. 2008033532.
  • polymeric materials for the skeletons of stents is a rare technical solution.
  • One of the commercially available solutions represents the polymer stent Polyflex manufactured by the Boston Scientific company.
  • Another example of contemporary technical solutions is disclosed in the patent document EP 1258229 A1.
  • the plastic stent is mainly intended for the application in the vascular system.
  • a radiopaque filler is intermixed with a degradable polymer to form a dispersion.
  • the dispersion is then applied onto the finished stent using a dipping or spraying process.
  • the stent is prepared from polyethylene-terephtalate and polyethylene.
  • the stents may be covered, i.e. coated, with a foil.
  • a foil further enhances, the functionality of the stents, as disclosed, e.g., in the patent document U.S. 2010/0173066 describing a coated stent prepared by laser trimming.
  • the demands imposed on such a foil are considerable, The main parameter is the biological tolerability of the foil by the human body.
  • the foil must have adequate mechanical properties. Suitable tolerable materials include polymers on the basis of teflon, silicone, or polyurethane. When applied, the foil must be thin enough to enable the stent to be easily compressed when being inserted into the introduction system. This means that the stent must be coated with a thin, impermeable surface layer.
  • the impermeability is on of the most important parameters of coated stents.
  • the main task of the stent is to ensure the patency of a tubular organ and the foil must be able to enclose possible leaks, lesions or bleeding sutures, such as those caused by a resection.
  • Another important parameter of the foul is a certain level of elasticit which must correspond to the behaviour of the stent under deformation, as stated, e.g., in the patent document U.S. 2009220677:
  • stents are provided with diverse mechanisms.
  • the purpose of such mechanisms is to prevent the migration of the stent from the intended location.
  • the migration of the stent is prevented by the structure itself.
  • the stent In case that such stenotic structure, is not present, e.g. when a stent is imp!anted in connection with the treatment of esophageal fistulae, the stent must be forcibly retained in the intended location. As mentioned above, this may be accomplished by diverse retaining mechanisms.
  • One of the applicable principles consists in making both the proximal and the distal end of the stent flared so that the ends assume a tulip-like, dumbbell-like or "dog-bone-like" shape.
  • the proximal portion of the stent is flared to assume the tulip-like shape, the distal portion of the same remaining tubular in shape (U.S. 2008/0221670).
  • None of the above principles, however, is capable to completely eliminate any undesirable migration of the stent. Therefore, it is necessary to select an adequate combination of the above mentioned elements so that the risk of undesirable migration could be reduced to* an acceptable level.
  • Such closure does not obstruct the esophagus in any way and the food may freely pass through, as described in the document U.S. 2003/0060894.
  • Another alternative consists in the creation of overlapping natural obstructions which create a tortuous pathway inside the stent lumen. Overcoming of such closure in the reverse direction is virtually impossible but the stent remains open for supplying food.
  • Another advantage of the above solution consists in that the gas exchange remains unrestricted. This is not possible with the other solutions based on the use of the aforementioned sleeve element.
  • the stents are placed into the human body by means of endoscopic introducing and monitoring devices. Furthermore, x-ray or fluoroscopic imaging methods are used for the exact evaluation of the correct placement of stents. For this purpose, the stent must be sufficiently visible. In order to achieve this, the stents are provided with radiopaque markers at their proximal and distal ends. Alternatively, the stent itself may be made of a radiopaque material. By the way of example, the material known as Elgiloy may be referred to, where the core of the wire, which is formed from a radiopaque material, is coated with an alloy having shape memory. The respective composition is described in the patent document U.S. 5630840.
  • stents are mostly made of the materials, which are poorly visible in x- ray images, and so it remains necessary to provide them with radiopaque markers facilitating the corresponding introduction and extraction procedures.
  • the materials used for manufacturing such markers usually have high x-ray absorption coefficients and adequate thicknesses ensuring clear visibility of the markers. Therefore, the radiopaque markers are mostly made of precious metals, such as gold, platinum, iridium of combination thereof.
  • One of the drawbacks of the markers placed on a stent consists in that the stent is not visible along its entire length. The markers only indicate the proximal and distal ends of the stent or several specific portions of the same, as discernible from the patent application U.S. 2004/0044399.
  • halogen compounds which may be deposited onto the surface of the stent.
  • the stents Owing to the presence of halogen elements, the stents, such as those described in the patent document WO 2006/022754, are sufficiently visible in x-ray images.
  • the aforementioned enhancement techniques have many drawbacks.
  • the conventional radiopaque markers may suffer from galvanic corrosion when coming into contact with other elements having higher positive electric potentials. Such marker may also flake away or cause perforation of the wall of the affected organ inside the human body.
  • the deposited radiopaque layer may get stripped or washed away. All the above drawbacks may be overcome in that the radiopaque matter is directly embedded in the structure of the fibrous material.
  • stents are made of metallic materials that are, under certain circumstances, exposed to a more or less corrosive environment. Such corrosive environment may exist in the gastrointestinal tract. The bloodstream is also considered to be highly corrosive. In general, the corrosive environments impose considerable demands on medical devices that have to be implanted for an extended period of time. Corrosion is a significant electrochemical process that can cause an extensive damage to the implanted device. Due to mechanical and chemical stresses or to a combination thereof, the stent may be subject to severe local corrosion leading to the destruction of the same. Though rarely occurring, such cases may have disastrous or even fatal consequences with respect to the health status of the affected patient.
  • stents made of plastic materials may be either degradable or non-degradable.
  • the stent such as that according to the disclosure of WO 2009/099958, controllably decomposes into particles which can be eliminated by the human body.
  • the use of non-degradable plastic stents may be an adequate alternative for certain applications.
  • Such stent must be made of a plastic material that is sufficiently resistant in the environment of the human body and has adequate mechanical properties ensuring good expansion stret gth and overall mechanical behaviour.
  • the stent Polyflex manufactured by the Boston Scientific; company is made of a special polyester fibre which is provided with radiopaque strips at its proximal and distal ends as well as in its intermediate portion. The purpose of said radiopaque strips is to enhance the visibility of the stent in x-ray images. Nevertheless, the aforesaid stent has not a sufficient expansion strength and the respective material is strongly susceptible to deformation which might adversely influence the final shape of the stent.
  • Another disadvantage consists in that a sizable introduction device must be used, in which the stent is compressed prior to implantation, which makes the application of the stent arduous.
  • the objective of the present invention is to provide an alternative solution, wherein the stent would have improved mechanical properties, such as resistance to corrosion or sufficient shape memory.
  • the self-expanding dual polymeric stent which is prepared from plastic and radiopaque fibres coated by an elastic foil, according to the invention, wherein the stent has conical shape and is provided with an anti-migration segment and with extracting wires at its proximal end and with an anti-reflux valve at its distal end, said stent being made of two different non- degradable fibres, namely of the PEEK-based carrying fibre and the radiopaque fibre, and coated with a silicone foil, the carrying fibre forming the principal skeleton of the stent and the radiopaque fibre enhancing the visibility of the same, the carrying fibre being made of a plastic material selected from the group including PEEK, PEAK, PEK, PEKK, PEKKEK and the other fibre being made of PU+W, the stent further being provided with a pull-tie.
  • Method of manufacturing the non-degradable dual conical plastic stent according to the invention consists in that initially the stent is knitted from the first fibre by means of a braiding machine so that it assumes a tubular, slightly conical shape having the proximal end atraumatic and the distal end traumatic, then the skeleton of the stent is placed on a mandrel and the other, radiopaque fibre is enlaced into it, both the fibres being laid side by side, afterwards the mandrel with the stent attached to it is removed from the braiding machine and placed into a thermal device where the shape of the stent is thermally fixated by being subjected to a temperature between 120 °C and 250 °C, preferably between 140 °C and 200 °C, during a time interval from 10 to 120 minutes, preferably from 20 to 40 minutes, and finally the stent is provided with the anti-migration segment at its proximal end, said segment comprising one or more fibres forming a ripple at the
  • Fig. 1 shows a schematical view of the stent according to the invention and Fig. 2 shows a detailed view of the arrangement of the fibres.
  • the present invention discloses the dual stent 1 formed from an interlaced mesh work.
  • the dual stent is composed of two different plastic fibres. According to the invention, either plastic fibre has a different, specific function.
  • the first meshwork comprises the carrying fibre 2 which is made of the material on the basis of PEEK, polyethersulfone or polyamide.
  • the second meshwork comprises the radiopaque fibre 3 which is enlaced into the structure of the stent 1 in order to supplement the carrying fibre and to ensure the clear visibility of the entire stent in x-ray images.
  • the stent is provided with the anti-migration segment 4 at the proximal end. Said segment, also referred to as collar, has corrugated shape and extends around the entire circumference of the proximal portion.
  • the collar is situated at the end of the dual stent or underneath that end.
  • the collar is situated in the distance of about 10 mm from the proximal end of the stent.
  • the total number, of such collars as well as the locations thereof may be variable.
  • the stent is provided with the pull- tie 5 at the proximal end, said pull-tie being enlaced into the individual meshes of the stent around the circumference of the same.
  • the pull tie may assume either the form of a wire or the form of an extraction lug. The number of such extraction lugs is not subject to any limitation.
  • a single extraction lug is considered' ⁇ be sufficient;
  • the pull-tie of the ste ⁇ ht is provided in the form of an extraction wire, the latter may be seized by means of a suitable extraction instrument.
  • Such extraction lugs or wires may be provided both at the proximal end and at the distal end of the stent, the number of those elements, again, being not subject to any limitation.
  • the function of the above elements is to enable the stent to be easily pulled into the respective extraction device.
  • the stent is provided with the anti-reflux valve 6 at the distal end, said anti-reflux valve having a sleeve-like shape.
  • the anti-reflux valve is perforated in order to enable the free escape of gases.
  • the size of the perforation in the anti-reflux valve 6 must be adequately selected in order to prevent the content of the stomach from passing through.
  • the skeleton of the stent 1 may be conical in shape which in itself further impedes the distal migration of the stent.
  • the skeleton of the stent may be coated with a silicone foil that covers the anti-migration segment at the proximal end of the stent and protrudes beyond the distal end of the same. In this case, the protruding portion of the foil forms the anti-reflux valve in itself.
  • only the skeleton of the stent is coated with the foil, the anti-migration elements being left blank.
  • the anti-reflux valve and the skeleton of the stent may be prepared from the same material. In case of a coated stent, the valve may be alternatively prepared from a different material. Afterwards, the anti-reflux valve is treated using either a chemical method (etching) or a mechanical method (punching) or an optical method (ablation) to assume the form of the selectively semi-pern eable membrane which is permeable to gases but impermeable to liquids.
  • the skeleton of the stent, the pull-tie forming the extraction wire, the extraction lug and the anti-migration collar are made of a material on the basis of polyetheretherketone (PEEK), polyimide or polyethersulfone.
  • the above materials are enriched with a radiopaque filler on the basis of barium, bismuth or tungsten salts.
  • the proportional content of such a filler should range between 20 and 60%, preferably between 40 and 50%.
  • the above compounds ensure that the stent will be clearly visible in x-ray images.
  • polymeric composite materials are considered. Owing to the composition of the above materials, the whole structure of the stent is visible which in turn makes the correct location, expansion and function of the same to be controllable.
  • the stent is covered with an elastic coat on the basis of polyurethane or silicone.
  • the coating material must be adequately elastic and rigid.
  • the material should be moderately cross-linked to form a polymeric grid.
  • the present invention provides a self-expanding dual plastic stent, said stent being conical in shape and comprising a composite material on the basis of polyetheretherketone, polyimide or polyethersulfone, said material forming the principal skeleton of the stent.
  • the stent further comprises a radiopaque fibre enhancing the visibility thereof, thus being also referred to as dual stent.
  • the stent is coated with an elastomeric foil extending along the entire length thereof.
  • the stent is provided with an extraction wire and an anti-migration collar that are arranged in the proximal portion of the stent.
  • the stent is provided with an anti-reflux valve at its distal end.
  • the stent Being made of a plastic material, the stent provides good mechanical properties, excellent resistance to corrosion and good shape memory.
  • Another advantage of the stent according to the invention consists in the possibility of using a compression device having a low diameter profile between 28F and 20F.
  • the intended field of application of the present, invention primarily comprises the gastrointestinal tract.
  • the esophagus, the transitional portions of the esophagus and stomach and those of the stomach and small intestine respectively, the small intestine, the colon and the rectum are mainly concerned.
  • the possible secondary applications involve the biliary, urethral, renal and pancreatic tracts.
  • Another preferred field of application of the invention involves the indications of the stents in respiratory tract, including both the trachea and the bronchi / bronchioles.
  • the stent according to the invention may also be applicable in the lacrimal pathways. When adequately adapted, the stent might be applicable in the vascular system. Although the latter field of application is feasible, it does not primarily fall into the scope of the present invention.
  • the foreseen clinical indications include benign and, malignant stenoses, and anastomotic leaks. Furthermore, the clinical indications may include implantations of stents having the purpose to cover up fistulae.
  • the primary field of application of the present invention consists in ensuring the patency of the above mentioned tubular organs in the human body.
  • the stent as a mechanical supporting element for transplanted organs, such us the trachea, in which case the stent is left inside the recipient's body until the adoption of the donated organ by the latter, in tne latter manner, the stent may be implanted into any part of the human body when a tubular organ is to be substituted resected.
  • the stent is manufactured using the following method: The individual steps are listed in the exact, consecutive order.
  • the stent is knitted from the first fibre by means of a braiding machine so that it assumes a tubular, slightly conical shape having the proximal end atraumatic (the fibre is bent) and, the distal end traumatic (the end is not formed from bent fibres but is terminated by a sharp edge of one of the fibres).
  • the skeleton of the stent is placed on a mandrel and the other, radiopaque fibre is enlaced into it, the technique being the same as that described in the preceding paragraph. Both the fibres are arranged side by side.
  • the radiopaque fibre may be less in diameter than that forming the skeleton of the stent.
  • the stent In this heat treatment stage, the stent subjected to a temperature between 120 °C and 250 °C, preferably between 140 °C and 200 °C, during a time interval from 10 to 120 minutes, preferably from 20 to 40 minutes.
  • the desirable shape memory is imparted to the material of the stent.
  • the stent is provided with the anti-migration segment at its proximal end, said segment comprising one or more fibres forming a' ipple at the proximal end of the stent, said ripple adjoining the skeleton of the stent from outside (when being introduced into the human body, the ripple will be dilating).
  • the anti-migration collar considerable reduces the risk of migration of the stent into the stomach but keeps both the shape and the exact positioning of the stent unchanged.
  • the anti-migration segment may be made of the same fibre or of a different one.
  • the stent is provided with a pull-tie facilitating the extraction of the same.
  • the pull-tie is attached to the stent in that the fibre forming the same is alternately interlaced between the individual links in the inward and outward directions over the entire circumference of the stent and terminated by a loop once the circumference is closed. A plurality of such loops may be optionally provided at either end of the stent.
  • the loops form a lug which may be handled in that its tab is seized and pulled, whether with an extractor or with pincers, causing the stent to be separated from a hollow organ lumen, such as esophagus. In a case of need, the stent may be displaced upwards. If the stent is provided with the pull-tie instead of the extraction wire, it may be handled in a similar manner.
  • the stent After having been stabilized in shape, the stent is undamped from the mandrel and made ready for being coated. Afterwards, the stent is attached to another mandrel, which is suitable for the subsequent coating process, and placed into a coating device. Neither the coating mandrel nor the coating device, however, fall into the scope of the present invention.
  • the meshwork of the stent is covered by a polymeric solution. Then, the stent is placed into a dryer where it undergoes the second heat treatment stage. During the latter stage, the shape memory of the material will be established and the coating of the stent will assume the cross-linked form.
  • the above mentioned second heat treatment is accomplished in the temperature range from 120 to 70 °C, preferably from 140 to 160 °C, during a time interval from 1 to 4 hours. After having undergone the second heat treatment, the stent is undamped from the mandrel, thus being ready for the next processing step.
  • the preparation of the anti-reflux valve is accomplished in the following way.
  • the distal portion of the stent is provided with the anti-reflux valve which is composed of a silicone or polyethylene foil having half the length of the stent.
  • the purpose of the anti-reflux valve is to prevent the gastric juice from penetrating into the esophagus.
  • the preparation is accomplished in the following way.
  • the coated stent is released from the coating mandrel and attached to another mandrel which serves as a supporting device.
  • a piece of PE foil having the desired shape is cut away from a reel.
  • the piece of foil is then trimmed to assume the required size, i.e. diameter and length.
  • the sleeve is attached to the stent (using an adhesive or by means of a thermal method).
  • the present invention may be exploited to ensure the patency of the hollow organs in the human body.
  • the stent is intended for tubular human organs, particularly for those of the gastrointestinal and respiratory tracts.
  • the gastrointestinal tract the may fields of application include the esophagus, the transitional area between the esophagus and stomach, the stomach, the duodenum sections, the small intestine, the colon and the rectum.
  • the stent may be implanted into the hollow organs which are directly connected to the gastrointestinal tract, such as into the biliary and pancreatic tracts.
  • the stent may also be applied in the urethra or in the ureters.
  • the main areas of application of the stents are the trachea and the bronchi / bronchioles.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Prostheses (AREA)

Abstract

La présente invention concerne un double stent en plastique non dégradable et auto-expansible, de forme conique et doté d'un segment anti-migration (4), ainsi que de fils d'extraction au niveau de son extrémité proximale et d'une valve anti-reflux (6) au niveau de son extrémité distale. Le stent est constitué de deux fibres non dégradables différentes, plus précisément de la fibre porteuse à base de PEEK (2) et de la fibre radio-opaque (3), et revêtu d'une feuille de silicone, la fibre porteuse (2) formant le squelette principal du stent (1) et la fibre radio-opaque (3) en améliorant la visibilité, la fibre porteuse (2) étant en une matière plastique choisie dans le groupe comprenant les PEEK, PEAK, PEK, PEKK, PEKKEK et l'autre fibre étant en PU + W. Le stent (1) est en outre doté d'un lien de serrage (5). La présente invention concerne également un procédé de fabrication dudit double stent en plastique, conique et non dégradable, le stent étant initialement tricoté à partir de la première fibre à l'aide d'un métier à tresser de manière à ce qu'il prenne une forme tubulaire/légèrement conique dont l'extrémité proximale est atraumatique et dont l'extrémité distale est traumatique, puis le squelette du stent est placé sur un mandrin et l'autre fibre, radio-opaque, est enlacée dans ledit squelette, les deux fibres reposant côte à côté, après quoi le mandrin sur lequel se trouve le stent est retiré du métier à tresser et placé dans un dispositif thermique où la forme du stent est thermiquement fixée par soumission à une température comprise entre 120°C et 250°C, de préférence entre 140°C et 200°C, pendant une durée comprise entre 10 et 120 minutes, de préférence entre 20 et 40 minutes, et finalement, le stent est doté du segment anti-migration au niveau de son extrémité proximale, ledit segment comprenant une ou plusieurs fibres formant un bourrelet au niveau de l'extrémité proximale du stent, ledit bourrelet étant adjacent au squelette du stent par l'extérieur.
EP11785280.6A 2011-08-26 2011-08-26 Double stent en plastique auto-expansible Withdrawn EP2747704A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CZ2011/000080 WO2013029572A1 (fr) 2011-08-26 2011-08-26 Double stent en plastique auto-expansible

Publications (1)

Publication Number Publication Date
EP2747704A1 true EP2747704A1 (fr) 2014-07-02

Family

ID=45001568

Family Applications (1)

Application Number Title Priority Date Filing Date
EP11785280.6A Withdrawn EP2747704A1 (fr) 2011-08-26 2011-08-26 Double stent en plastique auto-expansible

Country Status (3)

Country Link
EP (1) EP2747704A1 (fr)
KR (1) KR20140068092A (fr)
WO (1) WO2013029572A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6293853B1 (ja) * 2016-11-21 2018-03-14 ガデリウス・メディカル株式会社 弁付ステント
CZ309474B6 (cs) * 2021-02-12 2023-02-08 ELLA-CS, s.r.o Způsob výroby prostředku pro odstranění nevhodné tkáně

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5630840A (en) 1993-01-19 1997-05-20 Schneider (Usa) Inc Clad composite stent
US7118600B2 (en) 1998-08-31 2006-10-10 Wilson-Cook Medical, Inc. Prosthesis having a sleeve valve
EP1258229A1 (fr) 2001-05-15 2002-11-20 Vascular Technologies, Inc. Stents flexibles et élastiques et greffons vasculaires
DE10221076A1 (de) * 2002-05-11 2003-11-27 Ruesch Willy Gmbh Stent
US20040044399A1 (en) 2002-09-04 2004-03-04 Ventura Joseph A. Radiopaque links for self-expanding stents
US7637942B2 (en) 2002-11-05 2009-12-29 Merit Medical Systems, Inc. Coated stent with geometry determinated functionality and method of making the same
US20050255230A1 (en) 2004-05-17 2005-11-17 Clerc Claude O Method of manufacturing a covered stent
JP4982369B2 (ja) 2004-08-13 2012-07-25 ラトガース，ザ ステート ユニバーシティ 放射線不透過性の高分子ステント
EP1843719A1 (fr) * 2005-01-31 2007-10-17 Wilson-Cook Medical Inc. Prothese comportant une valve a manchon
US20070142903A1 (en) 2005-12-15 2007-06-21 Dave Vipul B Laser cut intraluminal medical devices
US8191142B2 (en) 2006-10-26 2012-05-29 Polytechnic Institute Of New York University Detecting whether an arbitrary-length bit string input matches one of a plurality of known arbitrary-length bit strings using a hierarchical data structure
CA2679691A1 (fr) 2007-03-07 2008-09-18 Boston Scientific Limited Endoprothese polymere radio-opaque
US20080255657A1 (en) * 2007-04-09 2008-10-16 Boston Scientific Scimed, Inc. Stent with unconnected stent segments
KR20090054493A (ko) 2007-11-27 2009-06-01 주식회사 에스앤지바이오텍 원통형 스텐트
WO2009091899A2 (fr) 2008-01-17 2009-07-23 Boston Scientific Scimed, Inc. Endoprothèse vasculaire avec caractéristique antimigratoire
US20090204203A1 (en) 2008-02-07 2009-08-13 Medtronic Vascular, Inc. Bioabsorbable Stent Having a Radiopaque Marker
EP2361594A4 (fr) 2009-07-10 2014-11-05 Taewoong Medical Co Ltd Endoprothèse
US20110054589A1 (en) * 2009-08-27 2011-03-03 Boston Scientific Scimed, Inc. Stent with variable cross section braiding filament and method for making same

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2013029572A1 *

Also Published As

Publication number Publication date
KR20140068092A (ko) 2014-06-05
WO2013029572A1 (fr) 2013-03-07

Similar Documents

Publication Publication Date Title
US11896474B2 (en) Stent including anti-migration capabilities
EP2874568B1 (fr) Dispositif médical implantable comprenant un manchon
US10278838B2 (en) Expandable stent delivery system with outer sheath
KR101937112B1 (ko) 관내 디바이스
KR101778696B1 (ko) 이식가능한 내강내 장치
US20110054589A1 (en) Stent with variable cross section braiding filament and method for making same
US20110270405A1 (en) Duodenal Metabolic Stent
US11147695B2 (en) Implantable medical device with reduced migration capabilities
US20100256735A1 (en) Intraluminal stent with seam
US20190262149A1 (en) Stent with anti-migration features
US20130218289A1 (en) Method and systems for determining preparedness of the uterus for delivery
US20240173152A1 (en) Stent including anti-migration capabilities
WO2013029572A1 (fr) Double stent en plastique auto-expansible
Kang Gastrointestinal stent update
CZ303466B6 (cs) Samoexpandovatelný dvojitý plastový stent
US20240164920A1 (en) Stent with selective membrane coating
US20240225869A1 (en) Apparatuses and methods of hybrid stent prostheses
WO2024206491A1 (fr) Endoprothèse à bride à double paroi anti-migration
KR200464309Y1 (ko) 이탈방지 스텐트
WO2024129588A1 (fr) Endoprothèse avec éléments anti-migration à auto-ajustement

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20140313

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAX Request for extension of the european patent (deleted)
GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

INTG Intention to grant announced

Effective date: 20150605

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20151016